About us Contacts Interactions: 118 620
Drug search by name

Ropinirole Extended-Release Tablets and Neuroleptic malignant syndrome

Result of checking the interaction of drug Ropinirole Extended-Release Tablets and disease Neuroleptic malignant syndrome for safety when used together.

Check result:
Ropinirole Extended-Release Tablets <> Neuroleptic malignant syndrome
Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

Neuroleptic malignant syndrome (NMS) has not occurred during administration of ropinirole, however, the syndrome has rarely been precipitated by rapid dosage reduction, abrupt discontinuation, or changes in other dopamine agonist therapy.

References:
  • "Product Information. Requip (ropinirole)." SmithKline Beecham, Philadelphia, PA.
Ropinirole Extended-Release Tablets

Generic Name: ropinirole

Brand Name: Requip, Requip XL, ReQuip Follow on Pack, ReQuip Starter Pack, Repreve, Requip Starter Kit

Synonyms: Ropinirole, ROPINIRole

What is Ropinirole Extended-Release Tablets?
Another drug Delete
The list of popular interactions
DiseDoc World
Interaction with food and lifestyle
  1. Ropinirole Extended-Release Tablets
Drug interactions
  1. Ropinirole Extended-Release Tablets
We use cookies to improve the site's performance. By continuing, you agree to use the cookies. OK